1-3 of 3
Peter de Nully Brown
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update

Open Access
Clinical Trials & Observations
Eva Kimby, Sämi Schär, Maria Cristina Pirosa, Anna Vanazzi, Ulrich M. Mey, Daniel Rauch, Björn E. Wahlin, Felicitas Hitz, Micaela Hernberg, Ann-Sofie Johansson, Peter de Nully Brown, Hans Hagberg, Andrés José María Ferreri, Fatime Krasniqi, Michèle Voegeli, Urban Novak, Thilo Zander, Hanne Bersvendsen, Christoph Mamot, Walter Mingrone, Anastasios Stathis, Stefan Dirnhofer, Stefanie Hayoz, Bjørn Østenstad, Emanuele Zucca
Journal: Blood Advances
Blood Adv (2025) 9 (7): 1712–1719.
https://doi.org/10.1182/bloodadvances.2024014840
Published: 2025
Includes: Supplemental data
Journal Articles

Sinonasal DLBCL: molecular profiling identifies subtypes with distinctive prognosis and targetable genetic features

Free
Patrick R. G. Eriksen, Fleur de Groot, Erik Clasen-Linde, Peter de Nully Brown, Ruben de Groen, Linea C. Melchior, Andrea D. Maier, Marthe Minderman, Joost S. P. Vermaat, Christian von Buchwald, Steven T. Pals, Steffen Heegaard
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1946–1957.
https://doi.org/10.1182/bloodadvances.2023011517
Published: 2024
Includes: Supplemental data
Journal Articles

Patients with high-risk DLBCL benefit from dose-dense immunochemotherapy combined with early systemic CNS prophylaxis

Free
Clinical Trials & Observations
Sirpa Leppä, Judit Jørgensen, Anne Tierens, Leo Meriranta, Ingunn Østlie, Peter de Nully Brown, Unn-Merete Fagerli, Thomas Stauffer Larsen, Susanna Mannisto, Lars Munksgaard, Martin Maisenhölder, Kaija Vasala, Peter Meyer, Mats Jerkeman, Magnus Björkholm, Øystein Fluge, Sirkku Jyrkkiö, Knut Liestøl, Elisabeth Ralfkiaer, Signe Spetalen, Klaus Beiske, Marja-Liisa Karjalainen-Lindsberg, Harald Holte
Journal: Blood Advances
Blood Adv (2020) 4 (9): 1906–1915.
https://doi.org/10.1182/bloodadvances.2020001518
Published: 2020
Includes: Supplemental data